[10-years experience with myelobromol treatment of myelofibrosis].
D001803:Blood Transfusion; D006410:Hematopoiesis / Q000187:drug effects; D006529:Hepatomegaly / Q000188:drug therapy; D006801:Humans; D008353:Mannitol / Q000031:analogs & derivatives*; D008927:Mitobronitol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010198:Pancytopenia / Q000139:chemically induced / Q000628:therapy; D011086:Polycythemia / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013163:Splenomegaly / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced; D013922:Thrombocytosis / Q000188:drug therapy
D008353:Mannitol; D008927:Mitobronitol; D011241:Prednisone
Desiatiletnyi opyt lecheniia mielobromolom bol'nykh mielofibrozom.